XML 16 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 19,399 $ 42,863
Interest and accounts receivable, net 7,384 1,803
Marketable investments 500 1,034
Other current assets 1,189 1,727
Total current assets 28,472 47,427
Finance receivables, net 212,959 181,553
Marketable investments 88 119
Cost method investment 3,491 3,491
Deferred tax assets, net 17,350 20,539
Warrant assets 5,140 3,419
Intangible assets, net 8,615 9,964
Goodwill 8,404 8,404
Property and equipment, net 5,945 5,779
Other non-current assets 1,802 1,970
Total assets 292,266 282,665
Current liabilities:    
Accounts payable and accrued liabilities 4,746 5,087
Revolving credit facility 8
Total current liabilities 4,746 5,095
Contingent consideration payable 8,530 8,530
Other non-current liabilities 1,544 1,804
Total liabilities 14,820 15,429
Stockholders’ equity:    
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,835,304 and 12,836,133 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively 13 13
Additional paid-in capital 4,431,270 4,431,719
Accumulated deficit (4,153,837) (4,164,496)
Total stockholders’ equity 277,446 267,236
Total liabilities and stockholders’ equity $ 292,266 $ 282,665